Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5126)
All Articles published online
|
Jun 7, 2006 (publication date) through Mar 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Becker J, Müller-Tidow C, Serve H, Domschke W, Pohle T. Role of receptor tyrosine kinases in gastric cancer: New targets for a selective therapy. World J Gastroenterol 2006; 12(21): 3297-3305 [PMID: 16733844 DOI: 10.3748/wjg.v12.i21.3297] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i21/3297.htm |
| Number | Citing Articles |
| 1 |
Mariko Oki, Hiroyuki Yamamoto, Hiroaki Taniguchi, Yasushi Adachi, Kohzoh Imai, Yasuhisa Shinomura. Overexpression of the receptor tyrosine kinase EphA4 in human gastric cancers. World Journal of Gastroenterology 2008; 14(37): 5650-5656 doi: 10.3748/wjg.14.5650
|
| 2 |
Hirokazu Fukui, Yoshikazu Kinoshita, Tsutomu Chiba. The Biology of Gastric Cancers. 2009; : 541 doi: 10.1007/978-0-387-69182-4_21
|
| 3 |
SHI LIU, JIAN GONG, ASAHIRO MORISHITA, TAKAKO NOMURA, HISAAKI MIYOSHI, JOJI TANI, KIYOHITO KATO, HIROHITO YONEYAMA, AKIHIRO DEGUCHI, HIROHITO MORI, SHIMA MIMURA, KEI NOMURA, TAKASHI HIMOTO, KAZUSHI DEGUCHI, KEIICHI OKANO, KUNIHIKO IZUISHI, YASUYUKI SUZUKI, YOSHIO KUSHIDA, REIJI HABA, HISAKAZU IWAMA, TSUTOMU MASAKI. Use of protein array technology to investigate receptor tyrosine kinases activated in hepatocellular carcinoma. Experimental and Therapeutic Medicine 2011; 2(3): 399 doi: 10.3892/etm.2011.215
|
| 4 |
M Yashiro, H Qiu, T Hasegawa, X Zhang, T Matsuzaki, K Hirakawa. An EGFR inhibitor enhances the efficacy of SN38, an active metabolite of irinotecan, in SN38-refractory gastric carcinoma cells. British Journal of Cancer 2011; 105(10): 1522 doi: 10.1038/bjc.2011.397
|
| 5 |
Deepika Sarvepalli, Mamoon Ur Rashid, Hammad Zafar, Sundas Jehanzeb, Effa Zahid, Sarfraz Ahmad. Overcoming Drug Resistance in Gynecologic Cancers. 2021; : 283 doi: 10.1016/B978-0-12-824299-5.00014-9
|
| 6 |
Asad ur Rahman, Deepika Sarvepalli, Mamoon Ur Rashid, Saeed Ali, Awais Naeem, Asif Imran, Effa Zahid, Sarfraz Ahmad. Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers. 2020; : 169 doi: 10.1007/978-3-030-48405-7_8
|
| 7 |
A. Thalheimer, S. Braendlein, P. Vollmers, A. Thiede, D. Meyer, B. Illert. Antikörpertherapie in klinischer und präklinischer Anwendung bei gastrointestinalen Karzinomen. Der Onkologe 2007; 13(3): 236 doi: 10.1007/s00761-007-1190-3
|
| 8 |
William B. Robb, Christophe Mariette. Early Gastrointestinal Cancers. Recent Results in Cancer Research 2012; 196: 241 doi: 10.1007/978-3-642-31629-6_17
|
| 9 |
Ron Shaoul, Liat Eliahu, Ifat Sher, Yaheli Hamlet, Ines Miselevich, Orit Goldshmidt, Dina Ron. Elevated expression of FGF7 protein is common in human gastric diseases. Biochemical and Biophysical Research Communications 2006; 350(4): 825 doi: 10.1016/j.bbrc.2006.08.198
|
| 10 |
Mahdi Shabani, Hossein Asgarian-Omran, Parvaneh Vossough, Ramazan A. Sharifian, Mohammad Faranoush, Soheila Ghragozlou, Jalal Khoshnoodi, Azam Roohi, Mahmood Jeddi-Tehrani, Hakan Mellstedt, Hodjatallah Rabbani, Fazel Shokri. Expression profile of orphan receptor tyrosine kinase (ROR1) and Wilms' tumor gene 1 (WT1) in different subsets of B-cell acute lymphoblastic leukemia. Leukemia & Lymphoma 2008; 49(7): 1360 doi: 10.1080/10428190802124000
|
| 11 |
Md. Moshfekus Saleh-e-In, Ayan Roy, Muhammad Abdullah Al-Mansur, Choudhury Mahmood Hasan, Md. Matiur Rahim, Nasim Sultana, Shamim Ahmed, Md. Rabiul Islam, Johannes van Staden. Isolation and in silico prediction of potential drug-like compounds from Anethum sowa L. root extracts targeted towards cancer therapy. Computational Biology and Chemistry 2019; 78: 242 doi: 10.1016/j.compbiolchem.2018.11.025
|
| 12 |
Abbes Belkhiri, Shoumin Zhu, Zheng Chen, Mohammed Soutto, Wael El-Rifai. Resistance to TRAIL Is Mediated by DARPP-32 in Gastric Cancer. Clinical Cancer Research 2012; 18(14): 3889 doi: 10.1158/1078-0432.CCR-11-3182
|
| 13 |
Muzammil Muhammad Khan, Deepika Sarvepalli, Mamoon Ur Rashid, Hammad Zafar, Muhammad Shayan Khan, Effa Zahid, Akash Khetpal, Bayarmaa Mandzhieva, Rima Shobar, Anum Jalil, Sarfraz Ahmad. Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers. 2020; : 189 doi: 10.1007/978-3-030-48405-7_9
|
| 14 |
Reza Panahizadeh, Padideh Panahi, Vahid Asghariazar, Shima Makaremi, Ghasem Noorkhajavi, Elham Safarzadeh. A literature review of recent advances in gastric cancer treatment: exploring the cross-talk between targeted therapies. Cancer Cell International 2025; 25(1) doi: 10.1186/s12935-025-03655-8
|
| 15 |
Hai Qian, Kwaku Appiah-Kubi, Ying Wang, Min Wu, Yan Tao, Yan Wu, Yongchang Chen. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 2018; 127: 15 doi: 10.1016/j.critrevonc.2018.05.004
|
| 16 |
Kensei Yamaguchi, Nozomu Fuse, Yoshito Komatsu, Hirofumi Fujii, Shuichi Hironaka, Yasushi Omuro, Kei Muro, Hirofumi Yasui, Shinya Ueda, Tomohiro Nishina, Morihiro Watanabe, Atsushi Ohtsu. Phase II study of cetuximab plus S-1/cisplatin therapy in Japanese patients with advanced gastric cancer. Japanese Journal of Clinical Oncology 2021; 51(6): 879 doi: 10.1093/jjco/hyaa276
|
| 17 |
Haizhen Zhong, Ly M. Tran, Jenna L. Stang. Induced-fit docking studies of the active and inactive states of protein tyrosine kinases. Journal of Molecular Graphics and Modelling 2009; 28(4): 336 doi: 10.1016/j.jmgm.2009.08.012
|
| 18 |
Chin-Tung Chen, Hyaehwan Kim, David Liska, Sizhi Gao, James G. Christensen, Martin R. Weiser. MET Activation Mediates Resistance to Lapatinib Inhibition of HER2-Amplified Gastric Cancer Cells. Molecular Cancer Therapeutics 2012; 11(3): 660 doi: 10.1158/1535-7163.MCT-11-0754
|
| 19 |
Ying Wang, Kwaku Appiah‐Kubi, Ting Lan, Min Wu, Ji Pang, Hai Qian, Yan Tao, Lu Jiang, Yan Wu, Yongchang Chen. PKG II inhibits PDGF‐BB triggered biological activities by phosphorylating PDGFRβ in gastric cancer cells. Cell Biology International 2018; 42(10): 1358 doi: 10.1002/cbin.11020
|
| 20 |
Bianca E. Chichirau, Sebastian Diechler, Gernot Posselt, Silja Wessler. Tyrosine Kinases in Helicobacter pylori Infections and Gastric Cancer. Toxins 2019; 11(10): 591 doi: 10.3390/toxins11100591
|
| 21 |
|
| 22 |
Yung-Jue Bang, Yoon-Koo Kang, Won K. Kang, Narikazu Boku, Hyun C. Chung, Jen-Shi Chen, Toshihiko Doi, Yan Sun, Lin Shen, Shukui Qin, Wai-Tong Ng, Jennifer M. Tursi, Maria J. Lechuga, Dongrui Ray Lu, Ana Ruiz-Garcia, Alberto Sobrero. Phase II study of sunitinib as second-line treatment for advanced gastric cancer. Investigational New Drugs 2011; 29(6): 1449 doi: 10.1007/s10637-010-9438-y
|
| 23 |
Neelam Khetpal, Saeed Ali, Ranjeet Kumar, Mamoon Ur Rashid, Sarfraz Ahmad. Role of Tyrosine Kinases in Gastrointestinal Malignancies. 2018; : 29 doi: 10.1007/978-981-13-1486-5_3
|
| 24 |
Shioto Suzuki, Yoh Dobashi, Yayoi Hatakeyama, Ryosuke Tajiri, Takashi Fujimura, Carl H Heldin, Akishi Ooi. Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-659
|
| 25 |
Fan Lin, Hock Jin Tan, Jye Swei Guan, Yoon Pin Lim. Divide and conquer: subproteomic approaches toward gastric cancer biomarker and drug target discovery. Expert Review of Proteomics 2014; 11(4): 515 doi: 10.1586/14789450.2014.904751
|
| 26 |
Cristina Díaz del Arco, Lourdes Estrada Muñoz, Elena Molina Roldán, Mª Ángeles Cerón Nieto, Luis Ortega Medina, Soledad García Gómez de las Heras, Mª Jesús Fernández Aceñero. Immunohistochemical classification of gastric cancer based on new molecular biomarkers: a potential predictor of survival. Virchows Archiv 2018; 473(6): 687 doi: 10.1007/s00428-018-2443-9
|
| 27 |
Zhiyang Peng, Yahui Liu, Yongbing Zheng, Rui Zhou. Gefitinib Induces Apoptosis of Gastric Cancer Cells by Promoting Glutaminolysis Through the MEK/ERK Signaling Pathway. Science of Advanced Materials 2023; 15(11): 1554 doi: 10.1166/sam.2023.4594
|
| 28 |
Jing Cai, Wanning Wang, Dan Cong, Yuansong Bai, Wenlong Zhang. Development of treatment strategies for advanced HER2-positive gastric cancer: Insights from clinical trials. Critical Reviews in Oncology/Hematology 2025; 207: 104617 doi: 10.1016/j.critrevonc.2025.104617
|
| 29 |
LU JIANG, YONGCHANG CHEN, YUEYING LI, TING LAN, MIN WU, YING WANG, HAI QIAN. Type II cGMP-dependent protein kinase inhibits ligand-induced activation of EGFR in gastric cancer cells. Molecular Medicine Reports 2014; 9(4): 1405 doi: 10.3892/mmr.2014.1942
|
| 30 |
Rachel J. Gibson, Joanne M. Bowen, Dorothy M.K. Keefe. Technological advances in mucositis research: New insights and new issues. Cancer Treatment Reviews 2008; 34(5): 476 doi: 10.1016/j.ctrv.2008.02.001
|
| 31 |
A. S. Solovyova, Yu. O. Sokolova, V. N. Anisimov, E. D. Bazhanova. Analysis of HER-2/neu Receptor Expression and the Level of Neuronal Apoptosis in HER-2/neu Transgenic Mice during Aging. Bulletin of Experimental Biology and Medicine 2019; 167(4): 512 doi: 10.1007/s10517-019-04562-5
|
| 32 |
Sara M. Johnson, B. Mark Evers. Translational Research in Gastric Malignancy. Surgical Oncology Clinics of North America 2008; 17(2): 323 doi: 10.1016/j.soc.2008.01.001
|
| 33 |
Shoumin Zhu, Abbes Belkhiri, Wael El-Rifai. DARPP-32 Increases Interactions Between Epidermal Growth Factor Receptor and ERBB3 to Promote Tumor Resistance to Gefitinib. Gastroenterology 2011; 141(5): 1738 doi: 10.1053/j.gastro.2011.06.070
|
| 34 |
Iman Shaheen, Noha Ibrahim. Detection of Orphan Receptor Tyrosine Kinase (ROR-1) Expression in Egyptian Pediatric Acute Lymphoblastic Leukemia. Fetal and Pediatric Pathology 2012; 31(3): 113 doi: 10.3109/15513815.2012.656825
|
| 35 |
Zheyu Song, Yuanyu Wu, Jiebing Yang, Dingquan Yang, Xuedong Fang. Progress in the treatment of advanced gastric cancer. Tumor Biology 2017; 39(7): 101042831771462 doi: 10.1177/1010428317714626
|
| 36 |
Emma Portnoy, Shimon Lecht, Philip Lazarovici, Dganit Danino, Shlomo Magdassi. Cetuximab-labeled liposomes containing near-infrared probe for in vivo imaging. Nanomedicine: Nanotechnology, Biology and Medicine 2011; 7(4): 480 doi: 10.1016/j.nano.2011.01.001
|
| 37 |
Francesca Di Fabio, Carmine Pinto, Fabiola L. Rojas Llimpe, Stefano Fanti, Paolo Castellucci, Ciro Longobardi, Vita Mutri, Chiara Funaioli, Francesca Sperandi, Stefania Giaquinta, Andrea A. Martoni. The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab. Gastric Cancer 2007; 10(4): 221 doi: 10.1007/s10120-007-0438-3
|
| 38 |
Antarpreet Kaur, Constantin A Dasanu. Targeting the HER2 pathway for the therapy of lower esophageal and gastric adenocarcinoma. Expert Opinion on Pharmacotherapy 2011; 12(16): 2493 doi: 10.1517/14656566.2011.605354
|
| 39 |
Charu Sonkar, Pawan Kumar Doharey, Anuranjan Singh Rathore, Vishal Singh, Dharmendra Kashyap, Amaresh Kumar Sahoo, Nitish Mittal, Bechan Sharma, Hem Chandra Jha. Repurposing of gastric cancer drugs against COVID-19. Computers in Biology and Medicine 2021; 137: 104826 doi: 10.1016/j.compbiomed.2021.104826
|
| 40 |
Katrine R. Schoennemann, Jon K. Bjerregaard, Tine P. Hansen, Karin De Stricker, Morten F. Gjerstorff, Helle A. Jensen, Lene W. Vestermark, Per Pfeiffer. Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum. Gastric Cancer 2011; 14(3): 219 doi: 10.1007/s10120-011-0031-7
|
| 41 |
M. Moehler, A. Mueller, J.T. Hartmann, M.P. Ebert, S.E. Al-Batran, P. Reimer, M. Weihrauch, F. Lordick, T. Trarbach, S. Biesterfeld, M. Kabisch, D. Wachtlin, P.R. Galle. An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer. European Journal of Cancer 2011; 47(10): 1511 doi: 10.1016/j.ejca.2011.04.006
|
| 42 |
Fernando Rivera, M Eugenia Vega-Villegas, Marta F. López-Brea. Chemotherapy of advanced gastric cancer. Cancer Treatment Reviews 2007; 33(4): 315 doi: 10.1016/j.ctrv.2007.01.004
|